Jonathan Michael Yarimi is a Miramar, Florida based neurologist who is specialized in Neurology. Active license number of Jonathan Michael Yarimi is ME167413 for Child Neurology in Florida. His current practice location is 1971 Sw 172nd Ave Ste 200, Miramar. Patients can reach him at 954-265-2423. Jonathan Michael Yarimi is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1588170161. Jonathan Michael Yarimi specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Jonathan Michael Yarimi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1588170161
NPI Enumeration Date:
19 Dec, 2017
NPI Last Update On:
30 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jonathan Michael Yarimi are as mentioned below.
License Number
Specialization
State
Status
ME167413
Child Neurology
Florida
Primary
T2979
Pediatrics
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Jonathan Michael Yarimi 1971 Sw 172nd Ave Ste 200, Miramar, Florida
Zip:
33029-5592
Phone Number:
954-265-2423
Patients can reach Jonathan Michael Yarimi at 1971 Sw 172nd Ave Ste 200, Miramar, Florida or can call to book an appointment on 954-265-2423.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.